About this trial
Understanding mechanisms of mucus clearance from the airways may lead to treatments in muco-obstructive lung conditions. Mucociliary clearance (MCC) scans are a way to measure the rate at which a person's lungs can clear inhaled particles. Through a single-arm pilot study in participants with primary ciliary dyskinesia (PCD), the investigators will evaluate the effect of exercise as a way to increase clearance through a mechanism called gas liquid transport (GLT) where the faster flow of air through the lungs during exercise is able to clear more particles. The investigators will repeat MCC measures with exercise after administering hypertonic saline (HS) to evaluate the effects of mucus hydration on both GLT and cough clearance (CC).
Aim 1. To quantify non-ciliary, non-cough mechanisms of mucus clearance (i.e., GLT) in PCD through an MCC protocol that introduces a standardized exercise intervention after isotope delivery.
Aim 2. To evaluate whether exercise-induced GLT and/or CC are responsive to hydrator intervention, using a short acting bronchodilator with 7% HS prior to isotope delivery followed by MCC with exercise intervention.
Eligibility criteria
Qualifiers
18 years old or older
Diagnosis of PCD with supporting genetics
Lung function with forced expiratory volume in 1 second (FEV1) percent predicted >30%
Ability to exercise for 20 minutes (Exercise Assessment performed at screening visit)
Disqualifiers
Intolerance to 7% HS
Failure of HS tolerance test (HSTT) at visit 1 (V1), defined as a decline of 10% in FEV1 from baseline pre-bronchodilator (BD) FEV1 after 7% HS
Intolerance to levalbuterol
Exercise-induced asthma
Trial design
Treatments tested in this trial
- Exercise
- HS pretreatment with Exercise
Treatment groups
Sponsors and collaborators
University of North Carolina, Chapel Hill
Lead sponsor
Cystic Fibrosis Foundation
Collaborator